Global Parkinson Disease Drug Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Parkinson Disease Drug market size is predicted to grow from US$ 6057 million in 2025 to US$ 8784 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
LPI (LP Information)' newest research report, the “Parkinson Disease Drug Industry Forecast” looks at past sales and reviews total world Parkinson Disease Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Parkinson Disease Drug sales for 2025 through 2031. With Parkinson Disease Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parkinson Disease Drug industry.
This Insight Report provides a comprehensive analysis of the global Parkinson Disease Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Parkinson Disease Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parkinson Disease Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parkinson Disease Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parkinson Disease Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson Disease Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Parkinson Disease Drug market size is predicted to grow from US$ 6057 million in 2025 to US$ 8784 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
LPI (LP Information)' newest research report, the “Parkinson Disease Drug Industry Forecast” looks at past sales and reviews total world Parkinson Disease Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Parkinson Disease Drug sales for 2025 through 2031. With Parkinson Disease Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parkinson Disease Drug industry.
This Insight Report provides a comprehensive analysis of the global Parkinson Disease Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Parkinson Disease Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parkinson Disease Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parkinson Disease Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parkinson Disease Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson Disease Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Sinemet-CR
- Trastal
- Madopar
- COMT Inhibitor
- Other
- Under 40 Years Old
- 40-65 Years Old
- Above 65 Years Old
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Akorn
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Desitin Arzneimittel
- Endo Pharmaceuticals
- F.Hoffmann-La Roche
- H.Lundbeck
- Valeant
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Bausch Health
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson Disease Drug Market Size (2020-2031)
2.1.2 Parkinson Disease Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Parkinson Disease Drug by Country/Region (2020, 2024 & 2031)
2.2 Parkinson Disease Drug Segment by Type
2.2.1 Sinemet-CR
2.2.2 Trastal
2.2.3 Madopar
2.2.4 COMT Inhibitor
2.2.5 Other
2.3 Parkinson Disease Drug Market Size by Type
2.3.1 Parkinson Disease Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Parkinson Disease Drug Market Size Market Share by Type (2020-2025)
2.4 Parkinson Disease Drug Segment by Application
2.4.1 Under 40 Years Old
2.4.2 40-65 Years Old
2.4.3 Above 65 Years Old
2.5 Parkinson Disease Drug Market Size by Application
2.5.1 Parkinson Disease Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
3 PARKINSON DISEASE DRUG MARKET SIZE BY PLAYER
3.1 Parkinson Disease Drug Market Size Market Share by Player
3.1.1 Global Parkinson Disease Drug Revenue by Player (2020-2025)
3.1.2 Global Parkinson Disease Drug Revenue Market Share by Player (2020-2025)
3.2 Global Parkinson Disease Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON DISEASE DRUG BY REGION
4.1 Parkinson Disease Drug Market Size by Region (2020-2025)
4.2 Global Parkinson Disease Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Parkinson Disease Drug Market Size Growth (2020-2025)
4.4 APAC Parkinson Disease Drug Market Size Growth (2020-2025)
4.5 Europe Parkinson Disease Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Parkinson Disease Drug Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Parkinson Disease Drug Market Size by Country (2020-2025)
5.2 Americas Parkinson Disease Drug Market Size by Type (2020-2025)
5.3 Americas Parkinson Disease Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson Disease Drug Market Size by Region (2020-2025)
6.2 APAC Parkinson Disease Drug Market Size by Type (2020-2025)
6.3 APAC Parkinson Disease Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson Disease Drug Market Size by Country (2020-2025)
7.2 Europe Parkinson Disease Drug Market Size by Type (2020-2025)
7.3 Europe Parkinson Disease Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson Disease Drug by Region (2020-2025)
8.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Parkinson Disease Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON DISEASE DRUG MARKET FORECAST
10.1 Global Parkinson Disease Drug Forecast by Region (2026-2031)
10.1.1 Global Parkinson Disease Drug Forecast by Region (2026-2031)
10.1.2 Americas Parkinson Disease Drug Forecast
10.1.3 APAC Parkinson Disease Drug Forecast
10.1.4 Europe Parkinson Disease Drug Forecast
10.1.5 Middle East & Africa Parkinson Disease Drug Forecast
10.2 Americas Parkinson Disease Drug Forecast by Country (2026-2031)
10.2.1 United States Market Parkinson Disease Drug Forecast
10.2.2 Canada Market Parkinson Disease Drug Forecast
10.2.3 Mexico Market Parkinson Disease Drug Forecast
10.2.4 Brazil Market Parkinson Disease Drug Forecast
10.3 APAC Parkinson Disease Drug Forecast by Region (2026-2031)
10.3.1 China Parkinson Disease Drug Market Forecast
10.3.2 Japan Market Parkinson Disease Drug Forecast
10.3.3 Korea Market Parkinson Disease Drug Forecast
10.3.4 Southeast Asia Market Parkinson Disease Drug Forecast
10.3.5 India Market Parkinson Disease Drug Forecast
10.3.6 Australia Market Parkinson Disease Drug Forecast
10.4 Europe Parkinson Disease Drug Forecast by Country (2026-2031)
10.4.1 Germany Market Parkinson Disease Drug Forecast
10.4.2 France Market Parkinson Disease Drug Forecast
10.4.3 UK Market Parkinson Disease Drug Forecast
10.4.4 Italy Market Parkinson Disease Drug Forecast
10.4.5 Russia Market Parkinson Disease Drug Forecast
10.5 Middle East & Africa Parkinson Disease Drug Forecast by Region (2026-2031)
10.5.1 Egypt Market Parkinson Disease Drug Forecast
10.5.2 South Africa Market Parkinson Disease Drug Forecast
10.5.3 Israel Market Parkinson Disease Drug Forecast
10.5.4 Turkey Market Parkinson Disease Drug Forecast
10.6 Global Parkinson Disease Drug Forecast by Type (2026-2031)
10.7 Global Parkinson Disease Drug Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Parkinson Disease Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Parkinson Disease Drug Product Offered
11.1.3 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Akorn
11.2.1 Akorn Company Information
11.2.2 Akorn Parkinson Disease Drug Product Offered
11.2.3 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Akorn Main Business Overview
11.2.5 Akorn Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Parkinson Disease Drug Product Offered
11.3.3 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Parkinson Disease Drug Product Offered
11.4.3 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Offered
11.5.3 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Information
11.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Offered
11.6.3 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Teva Pharmaceutical Main Business Overview
11.6.5 Teva Pharmaceutical Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Parkinson Disease Drug Product Offered
11.7.3 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Information
11.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Kyowa Hakko Kirin Pharma Main Business Overview
11.8.5 Kyowa Hakko Kirin Pharma Latest Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Information
11.9.2 Astellas Pharma Parkinson Disease Drug Product Offered
11.9.3 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Astellas Pharma Main Business Overview
11.9.5 Astellas Pharma Latest Developments
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Information
11.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Offered
11.10.3 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Desitin Arzneimittel Main Business Overview
11.10.5 Desitin Arzneimittel Latest Developments
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Information
11.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Offered
11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Endo Pharmaceuticals Main Business Overview
11.11.5 Endo Pharmaceuticals Latest Developments
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Information
11.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Offered
11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 F.Hoffmann-La Roche Main Business Overview
11.12.5 F.Hoffmann-La Roche Latest Developments
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Information
11.13.2 H.Lundbeck Parkinson Disease Drug Product Offered
11.13.3 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 H.Lundbeck Main Business Overview
11.13.5 H.Lundbeck Latest Developments
11.14 Valeant
11.14.1 Valeant Company Information
11.14.2 Valeant Parkinson Disease Drug Product Offered
11.14.3 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Valeant Main Business Overview
11.14.5 Valeant Latest Developments
11.15 Apokyn
11.15.1 Apokyn Company Information
11.15.2 Apokyn Parkinson Disease Drug Product Offered
11.15.3 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Apokyn Main Business Overview
11.15.5 Apokyn Latest Developments
11.16 Orion
11.16.1 Orion Company Information
11.16.2 Orion Parkinson Disease Drug Product Offered
11.16.3 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Orion Main Business Overview
11.16.5 Orion Latest Developments
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Information
11.17.2 Stada Arzneimittel Parkinson Disease Drug Product Offered
11.17.3 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Stada Arzneimittel Main Business Overview
11.17.5 Stada Arzneimittel Latest Developments
11.18 US WorldMeds
11.18.1 US WorldMeds Company Information
11.18.2 US WorldMeds Parkinson Disease Drug Product Offered
11.18.3 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 US WorldMeds Main Business Overview
11.18.5 US WorldMeds Latest Developments
11.19 Bausch Health
11.19.1 Bausch Health Company Information
11.19.2 Bausch Health Parkinson Disease Drug Product Offered
11.19.3 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Bausch Health Main Business Overview
11.19.5 Bausch Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Parkinson Disease Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Parkinson Disease Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sinemet-CR
Table 4. Major Players ofTrastal
Table 5. Major Players of Madopar
Table 6. Major Players of COMT Inhibitor
Table 7. Major Players of Other
Table 8. Parkinson Disease Drug Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 10. Global Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Table 11. Parkinson Disease Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Table 14. Global Parkinson Disease Drug Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Parkinson Disease Drug Revenue Market Share by Player (2020-2025)
Table 16. Parkinson Disease Drug Key Players Head office and Products Offered
Table 17. Parkinson Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Parkinson Disease Drug Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Parkinson Disease Drug Market Size Market Share by Region (2020-2025)
Table 22. Global Parkinson Disease Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Parkinson Disease Drug Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Parkinson Disease Drug Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Parkinson Disease Drug Market Size Market Share by Country (2020-2025)
Table 26. Americas Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 27. Americas Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Table 28. Americas Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Table 30. APAC Parkinson Disease Drug Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Parkinson Disease Drug Market Size Market Share by Region (2020-2025)
Table 32. APAC Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 33. APAC Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Parkinson Disease Drug Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Parkinson Disease Drug Market Size Market Share by Country (2020-2025)
Table 36. Europe Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 37. Europe Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Parkinson Disease Drug Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & Africa Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Parkinson Disease Drug
Table 42. Key Market Challenges & Risks of Parkinson Disease Drug
Table 43. Key IndustryTrends of Parkinson Disease Drug
Table 44. Global Parkinson Disease Drug Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. Global Parkinson Disease Drug Market Size Market ShareForecast by Region (2026-2031)
Table 46. Global Parkinson Disease Drug Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. Global Parkinson Disease Drug Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Merck Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 49. Merck Parkinson Disease Drug Product Offered
Table 50. Merck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Merck Main Business
Table 52. Merck Latest Developments
Table 53. Akorn Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 54. Akorn Parkinson Disease Drug Product Offered
Table 55. Akorn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Akorn Main Business
Table 57. Akorn Latest Developments
Table 58. GSK Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 59. GSK Parkinson Disease Drug Product Offered
Table 60. GSK Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. GSK Main Business
Table 62. GSK Latest Developments
Table 63. Novartis Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 64. Novartis Parkinson Disease Drug Product Offered
Table 65. Novartis Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Novartis Main Business
Table 67. Novartis Latest Developments
Table 68. Boehringer Ingelheim Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 69. Boehringer Ingelheim Parkinson Disease Drug Product Offered
Table 70. Boehringer Ingelheim Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Boehringer Ingelheim Main Business
Table 72. Boehringer Ingelheim Latest Developments
Table 73.Teva Pharmaceutical Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 74.Teva Pharmaceutical Parkinson Disease Drug Product Offered
Table 75.Teva Pharmaceutical Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76.Teva Pharmaceutical Main Business
Table 77.Teva Pharmaceutical Latest Developments
Table 78. Abbvie Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 79. Abbvie Parkinson Disease Drug Product Offered
Table 80. Abbvie Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Abbvie Main Business
Table 82. Abbvie Latest Developments
Table 83. Kyowa Hakko Kirin Pharma Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 84. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered
Table 85. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Kyowa Hakko Kirin Pharma Main Business
Table 87. Kyowa Hakko Kirin Pharma Latest Developments
Table 88. Astellas Pharma Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 89. Astellas Pharma Parkinson Disease Drug Product Offered
Table 90. Astellas Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Astellas Pharma Main Business
Table 92. Astellas Pharma Latest Developments
Table 93. Desitin Arzneimittel Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 94. Desitin Arzneimittel Parkinson Disease Drug Product Offered
Table 95. Desitin Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Desitin Arzneimittel Main Business
Table 97. Desitin Arzneimittel Latest Developments
Table 98. Endo Pharmaceuticals Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 99. Endo Pharmaceuticals Parkinson Disease Drug Product Offered
Table 100. Endo Pharmaceuticals Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Endo Pharmaceuticals Main Business
Table 102. Endo Pharmaceuticals Latest Developments
Table 103.F.Hoffmann-La Roche Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 104.F.Hoffmann-La Roche Parkinson Disease Drug Product Offered
Table 105.F.Hoffmann-La Roche Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106.F.Hoffmann-La Roche Main Business
Table 107.F.Hoffmann-La Roche Latest Developments
Table 108. H.Lundbeck Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 109. H.Lundbeck Parkinson Disease Drug Product Offered
Table 110. H.Lundbeck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. H.Lundbeck Main Business
Table 112. H.Lundbeck Latest Developments
Table 113. Valeant Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 114. Valeant Parkinson Disease Drug Product Offered
Table 115. Valeant Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Valeant Main Business
Table 117. Valeant Latest Developments
Table 118. Apokyn Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 119. Apokyn Parkinson Disease Drug Product Offered
Table 120. Apokyn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Apokyn Main Business
Table 122. Apokyn Latest Developments
Table 123. Orion Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 124. Orion Parkinson Disease Drug Product Offered
Table 125. Orion Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Orion Main Business
Table 127. Orion Latest Developments
Table 128. Stada Arzneimittel Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 129. Stada Arzneimittel Parkinson Disease Drug Product Offered
Table 130. Stada Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Stada Arzneimittel Main Business
Table 132. Stada Arzneimittel Latest Developments
Table 133. US WorldMeds Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 134. US WorldMeds Parkinson Disease Drug Product Offered
Table 135. US WorldMeds Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. US WorldMeds Main Business
Table 137. US WorldMeds Latest Developments
Table 138. Bausch Health Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 139. Bausch Health Parkinson Disease Drug Product Offered
Table 140. Bausch Health Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Bausch Health Main Business
Table 142. Bausch Health Latest Developments
LIST OFFIGURES
Figure 1. Parkinson Disease Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson Disease Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Parkinson Disease Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Parkinson Disease Drug Sales Market Share by Country/Region (2024)
Figure 8. Parkinson Disease Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Parkinson Disease Drug Market Size Market Share byType in 2024
Figure 10. Parkinson Disease Drug in Under 40 Years Old
Figure 11. Global Parkinson Disease Drug Market: Under 40 Years Old (2020-2025) & ($ millions)
Figure 12. Parkinson Disease Drug in 40-65 Years Old
Figure 13. Global Parkinson Disease Drug Market: 40-65 Years Old (2020-2025) & ($ millions)
Figure 14. Parkinson Disease Drug in Above 65 Years Old
Figure 15. Global Parkinson Disease Drug Market: Above 65 Years Old (2020-2025) & ($ millions)
Figure 16. Global Parkinson Disease Drug Market Size Market Share by Application in 2024
Figure 17. Global Parkinson Disease Drug Revenue Market Share by Player in 2024
Figure 18. Global Parkinson Disease Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas Parkinson Disease Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC Parkinson Disease Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe Parkinson Disease Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Parkinson Disease Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas Parkinson Disease Drug Value Market Share by Country in 2024
Figure 24. United States Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Parkinson Disease Drug Market Size Market Share by Region in 2024
Figure 29. APAC Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Figure 30. APAC Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Figure 31. China Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Parkinson Disease Drug Market Size Market Share by Country in 2024
Figure 38. Europe Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Figure 39. Europe Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 41.France Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 57. United States Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 61. China Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 65. India Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 68.France Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 69. UK Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 75.Turkey Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 76. Global Parkinson Disease Drug Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Parkinson Disease Drug Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Parkinson Disease Drug Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson Disease Drug Market Size (2020-2031)
2.1.2 Parkinson Disease Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Parkinson Disease Drug by Country/Region (2020, 2024 & 2031)
2.2 Parkinson Disease Drug Segment by Type
2.2.1 Sinemet-CR
2.2.2 Trastal
2.2.3 Madopar
2.2.4 COMT Inhibitor
2.2.5 Other
2.3 Parkinson Disease Drug Market Size by Type
2.3.1 Parkinson Disease Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Parkinson Disease Drug Market Size Market Share by Type (2020-2025)
2.4 Parkinson Disease Drug Segment by Application
2.4.1 Under 40 Years Old
2.4.2 40-65 Years Old
2.4.3 Above 65 Years Old
2.5 Parkinson Disease Drug Market Size by Application
2.5.1 Parkinson Disease Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
3 PARKINSON DISEASE DRUG MARKET SIZE BY PLAYER
3.1 Parkinson Disease Drug Market Size Market Share by Player
3.1.1 Global Parkinson Disease Drug Revenue by Player (2020-2025)
3.1.2 Global Parkinson Disease Drug Revenue Market Share by Player (2020-2025)
3.2 Global Parkinson Disease Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON DISEASE DRUG BY REGION
4.1 Parkinson Disease Drug Market Size by Region (2020-2025)
4.2 Global Parkinson Disease Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Parkinson Disease Drug Market Size Growth (2020-2025)
4.4 APAC Parkinson Disease Drug Market Size Growth (2020-2025)
4.5 Europe Parkinson Disease Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Parkinson Disease Drug Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Parkinson Disease Drug Market Size by Country (2020-2025)
5.2 Americas Parkinson Disease Drug Market Size by Type (2020-2025)
5.3 Americas Parkinson Disease Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson Disease Drug Market Size by Region (2020-2025)
6.2 APAC Parkinson Disease Drug Market Size by Type (2020-2025)
6.3 APAC Parkinson Disease Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson Disease Drug Market Size by Country (2020-2025)
7.2 Europe Parkinson Disease Drug Market Size by Type (2020-2025)
7.3 Europe Parkinson Disease Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson Disease Drug by Region (2020-2025)
8.2 Middle East & Africa Parkinson Disease Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Parkinson Disease Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON DISEASE DRUG MARKET FORECAST
10.1 Global Parkinson Disease Drug Forecast by Region (2026-2031)
10.1.1 Global Parkinson Disease Drug Forecast by Region (2026-2031)
10.1.2 Americas Parkinson Disease Drug Forecast
10.1.3 APAC Parkinson Disease Drug Forecast
10.1.4 Europe Parkinson Disease Drug Forecast
10.1.5 Middle East & Africa Parkinson Disease Drug Forecast
10.2 Americas Parkinson Disease Drug Forecast by Country (2026-2031)
10.2.1 United States Market Parkinson Disease Drug Forecast
10.2.2 Canada Market Parkinson Disease Drug Forecast
10.2.3 Mexico Market Parkinson Disease Drug Forecast
10.2.4 Brazil Market Parkinson Disease Drug Forecast
10.3 APAC Parkinson Disease Drug Forecast by Region (2026-2031)
10.3.1 China Parkinson Disease Drug Market Forecast
10.3.2 Japan Market Parkinson Disease Drug Forecast
10.3.3 Korea Market Parkinson Disease Drug Forecast
10.3.4 Southeast Asia Market Parkinson Disease Drug Forecast
10.3.5 India Market Parkinson Disease Drug Forecast
10.3.6 Australia Market Parkinson Disease Drug Forecast
10.4 Europe Parkinson Disease Drug Forecast by Country (2026-2031)
10.4.1 Germany Market Parkinson Disease Drug Forecast
10.4.2 France Market Parkinson Disease Drug Forecast
10.4.3 UK Market Parkinson Disease Drug Forecast
10.4.4 Italy Market Parkinson Disease Drug Forecast
10.4.5 Russia Market Parkinson Disease Drug Forecast
10.5 Middle East & Africa Parkinson Disease Drug Forecast by Region (2026-2031)
10.5.1 Egypt Market Parkinson Disease Drug Forecast
10.5.2 South Africa Market Parkinson Disease Drug Forecast
10.5.3 Israel Market Parkinson Disease Drug Forecast
10.5.4 Turkey Market Parkinson Disease Drug Forecast
10.6 Global Parkinson Disease Drug Forecast by Type (2026-2031)
10.7 Global Parkinson Disease Drug Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Parkinson Disease Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Parkinson Disease Drug Product Offered
11.1.3 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Akorn
11.2.1 Akorn Company Information
11.2.2 Akorn Parkinson Disease Drug Product Offered
11.2.3 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Akorn Main Business Overview
11.2.5 Akorn Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Parkinson Disease Drug Product Offered
11.3.3 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Parkinson Disease Drug Product Offered
11.4.3 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Offered
11.5.3 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Information
11.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Offered
11.6.3 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Teva Pharmaceutical Main Business Overview
11.6.5 Teva Pharmaceutical Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Parkinson Disease Drug Product Offered
11.7.3 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Information
11.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Kyowa Hakko Kirin Pharma Main Business Overview
11.8.5 Kyowa Hakko Kirin Pharma Latest Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Information
11.9.2 Astellas Pharma Parkinson Disease Drug Product Offered
11.9.3 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Astellas Pharma Main Business Overview
11.9.5 Astellas Pharma Latest Developments
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Information
11.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Offered
11.10.3 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Desitin Arzneimittel Main Business Overview
11.10.5 Desitin Arzneimittel Latest Developments
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Information
11.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Offered
11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Endo Pharmaceuticals Main Business Overview
11.11.5 Endo Pharmaceuticals Latest Developments
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Information
11.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Offered
11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 F.Hoffmann-La Roche Main Business Overview
11.12.5 F.Hoffmann-La Roche Latest Developments
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Information
11.13.2 H.Lundbeck Parkinson Disease Drug Product Offered
11.13.3 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 H.Lundbeck Main Business Overview
11.13.5 H.Lundbeck Latest Developments
11.14 Valeant
11.14.1 Valeant Company Information
11.14.2 Valeant Parkinson Disease Drug Product Offered
11.14.3 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Valeant Main Business Overview
11.14.5 Valeant Latest Developments
11.15 Apokyn
11.15.1 Apokyn Company Information
11.15.2 Apokyn Parkinson Disease Drug Product Offered
11.15.3 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Apokyn Main Business Overview
11.15.5 Apokyn Latest Developments
11.16 Orion
11.16.1 Orion Company Information
11.16.2 Orion Parkinson Disease Drug Product Offered
11.16.3 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Orion Main Business Overview
11.16.5 Orion Latest Developments
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Information
11.17.2 Stada Arzneimittel Parkinson Disease Drug Product Offered
11.17.3 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Stada Arzneimittel Main Business Overview
11.17.5 Stada Arzneimittel Latest Developments
11.18 US WorldMeds
11.18.1 US WorldMeds Company Information
11.18.2 US WorldMeds Parkinson Disease Drug Product Offered
11.18.3 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 US WorldMeds Main Business Overview
11.18.5 US WorldMeds Latest Developments
11.19 Bausch Health
11.19.1 Bausch Health Company Information
11.19.2 Bausch Health Parkinson Disease Drug Product Offered
11.19.3 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Bausch Health Main Business Overview
11.19.5 Bausch Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Parkinson Disease Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Parkinson Disease Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sinemet-CR
Table 4. Major Players ofTrastal
Table 5. Major Players of Madopar
Table 6. Major Players of COMT Inhibitor
Table 7. Major Players of Other
Table 8. Parkinson Disease Drug Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 10. Global Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Table 11. Parkinson Disease Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Table 14. Global Parkinson Disease Drug Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Parkinson Disease Drug Revenue Market Share by Player (2020-2025)
Table 16. Parkinson Disease Drug Key Players Head office and Products Offered
Table 17. Parkinson Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Parkinson Disease Drug Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Parkinson Disease Drug Market Size Market Share by Region (2020-2025)
Table 22. Global Parkinson Disease Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Parkinson Disease Drug Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Parkinson Disease Drug Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Parkinson Disease Drug Market Size Market Share by Country (2020-2025)
Table 26. Americas Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 27. Americas Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Table 28. Americas Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Table 30. APAC Parkinson Disease Drug Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Parkinson Disease Drug Market Size Market Share by Region (2020-2025)
Table 32. APAC Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 33. APAC Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Parkinson Disease Drug Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Parkinson Disease Drug Market Size Market Share by Country (2020-2025)
Table 36. Europe Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 37. Europe Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Parkinson Disease Drug Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Parkinson Disease Drug Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & Africa Parkinson Disease Drug Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Parkinson Disease Drug
Table 42. Key Market Challenges & Risks of Parkinson Disease Drug
Table 43. Key IndustryTrends of Parkinson Disease Drug
Table 44. Global Parkinson Disease Drug Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. Global Parkinson Disease Drug Market Size Market ShareForecast by Region (2026-2031)
Table 46. Global Parkinson Disease Drug Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. Global Parkinson Disease Drug Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Merck Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 49. Merck Parkinson Disease Drug Product Offered
Table 50. Merck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Merck Main Business
Table 52. Merck Latest Developments
Table 53. Akorn Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 54. Akorn Parkinson Disease Drug Product Offered
Table 55. Akorn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Akorn Main Business
Table 57. Akorn Latest Developments
Table 58. GSK Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 59. GSK Parkinson Disease Drug Product Offered
Table 60. GSK Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. GSK Main Business
Table 62. GSK Latest Developments
Table 63. Novartis Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 64. Novartis Parkinson Disease Drug Product Offered
Table 65. Novartis Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Novartis Main Business
Table 67. Novartis Latest Developments
Table 68. Boehringer Ingelheim Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 69. Boehringer Ingelheim Parkinson Disease Drug Product Offered
Table 70. Boehringer Ingelheim Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Boehringer Ingelheim Main Business
Table 72. Boehringer Ingelheim Latest Developments
Table 73.Teva Pharmaceutical Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 74.Teva Pharmaceutical Parkinson Disease Drug Product Offered
Table 75.Teva Pharmaceutical Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76.Teva Pharmaceutical Main Business
Table 77.Teva Pharmaceutical Latest Developments
Table 78. Abbvie Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 79. Abbvie Parkinson Disease Drug Product Offered
Table 80. Abbvie Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Abbvie Main Business
Table 82. Abbvie Latest Developments
Table 83. Kyowa Hakko Kirin Pharma Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 84. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Offered
Table 85. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Kyowa Hakko Kirin Pharma Main Business
Table 87. Kyowa Hakko Kirin Pharma Latest Developments
Table 88. Astellas Pharma Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 89. Astellas Pharma Parkinson Disease Drug Product Offered
Table 90. Astellas Pharma Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Astellas Pharma Main Business
Table 92. Astellas Pharma Latest Developments
Table 93. Desitin Arzneimittel Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 94. Desitin Arzneimittel Parkinson Disease Drug Product Offered
Table 95. Desitin Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Desitin Arzneimittel Main Business
Table 97. Desitin Arzneimittel Latest Developments
Table 98. Endo Pharmaceuticals Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 99. Endo Pharmaceuticals Parkinson Disease Drug Product Offered
Table 100. Endo Pharmaceuticals Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Endo Pharmaceuticals Main Business
Table 102. Endo Pharmaceuticals Latest Developments
Table 103.F.Hoffmann-La Roche Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 104.F.Hoffmann-La Roche Parkinson Disease Drug Product Offered
Table 105.F.Hoffmann-La Roche Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106.F.Hoffmann-La Roche Main Business
Table 107.F.Hoffmann-La Roche Latest Developments
Table 108. H.Lundbeck Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 109. H.Lundbeck Parkinson Disease Drug Product Offered
Table 110. H.Lundbeck Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. H.Lundbeck Main Business
Table 112. H.Lundbeck Latest Developments
Table 113. Valeant Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 114. Valeant Parkinson Disease Drug Product Offered
Table 115. Valeant Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Valeant Main Business
Table 117. Valeant Latest Developments
Table 118. Apokyn Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 119. Apokyn Parkinson Disease Drug Product Offered
Table 120. Apokyn Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Apokyn Main Business
Table 122. Apokyn Latest Developments
Table 123. Orion Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 124. Orion Parkinson Disease Drug Product Offered
Table 125. Orion Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Orion Main Business
Table 127. Orion Latest Developments
Table 128. Stada Arzneimittel Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 129. Stada Arzneimittel Parkinson Disease Drug Product Offered
Table 130. Stada Arzneimittel Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Stada Arzneimittel Main Business
Table 132. Stada Arzneimittel Latest Developments
Table 133. US WorldMeds Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 134. US WorldMeds Parkinson Disease Drug Product Offered
Table 135. US WorldMeds Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. US WorldMeds Main Business
Table 137. US WorldMeds Latest Developments
Table 138. Bausch Health Details, CompanyType, Parkinson Disease Drug Area Served and Its Competitors
Table 139. Bausch Health Parkinson Disease Drug Product Offered
Table 140. Bausch Health Parkinson Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Bausch Health Main Business
Table 142. Bausch Health Latest Developments
LIST OFFIGURES
Figure 1. Parkinson Disease Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson Disease Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Parkinson Disease Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Parkinson Disease Drug Sales Market Share by Country/Region (2024)
Figure 8. Parkinson Disease Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Parkinson Disease Drug Market Size Market Share byType in 2024
Figure 10. Parkinson Disease Drug in Under 40 Years Old
Figure 11. Global Parkinson Disease Drug Market: Under 40 Years Old (2020-2025) & ($ millions)
Figure 12. Parkinson Disease Drug in 40-65 Years Old
Figure 13. Global Parkinson Disease Drug Market: 40-65 Years Old (2020-2025) & ($ millions)
Figure 14. Parkinson Disease Drug in Above 65 Years Old
Figure 15. Global Parkinson Disease Drug Market: Above 65 Years Old (2020-2025) & ($ millions)
Figure 16. Global Parkinson Disease Drug Market Size Market Share by Application in 2024
Figure 17. Global Parkinson Disease Drug Revenue Market Share by Player in 2024
Figure 18. Global Parkinson Disease Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas Parkinson Disease Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC Parkinson Disease Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe Parkinson Disease Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Parkinson Disease Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas Parkinson Disease Drug Value Market Share by Country in 2024
Figure 24. United States Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Parkinson Disease Drug Market Size Market Share by Region in 2024
Figure 29. APAC Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Figure 30. APAC Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Figure 31. China Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Parkinson Disease Drug Market Size Market Share by Country in 2024
Figure 38. Europe Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Figure 39. Europe Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 41.France Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Parkinson Disease Drug Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Parkinson Disease Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Parkinson Disease Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 57. United States Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 61. China Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 65. India Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 68.France Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 69. UK Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 75.Turkey Parkinson Disease Drug Market Size 2026-2031 ($ millions)
Figure 76. Global Parkinson Disease Drug Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Parkinson Disease Drug Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Parkinson Disease Drug Market Size 2026-2031 ($ millions)
